SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : BRLI-- A substantially undervalued micro-cap
BRLI 4.700-44.0%Dec 22 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Shutters who wrote (77)6/6/1998 1:33:00 PM
From: Tom Shutters  Read Replies (2) of 105
 
Linda, sorry but part of my post got lost.

"The pro forma condensed combined balance sheet assumes the acquisition was consummated on January 31, 1998. The pro forma condensed combined statements of operations give effect to this transaction as if it had occurred at the beginning of the earliest period presented. The pro forma condensed combined financial statements are based on the historical financial statements of the Company and Medilabs. These pro forma condensed combined financial statements may not be indicative of the results that actually would have occurred if the acquisition had taken place on the dates indicated."

It is my opinion that the Medilabs losses can be written off against BRLI's earnings and help pay the $5,500,000 paid for Medilabs. This would enhance the Medilabs deal. I would like to hear from a tax expert or anyone who has an opinion on this.

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext